119 results
Page 4 of 6
6-K
EX-99.3
7b01vrq5u4fq9wxx
5 Mar 15
Current report (foreign)
12:00am
6-K
EX-99
8jpur2xcf7lrkwu2
2 Mar 15
Current report (foreign)
12:00am
6-K
EX-99
5die9ctyb02kq24x
6 Jan 15
BioLineRx Completes Dose Escalation Stage of
12:00am
6-K
EX-99
yczedr8da8wwz xb
12 Dec 14
BioLineRx Presents Multi-Year Clinical Development
12:00am
6-K
EX-99
ge9i6r
12 Dec 14
Current report (foreign)
12:00am
6-K
EX-99
a9c7z eobw
8 Dec 14
BioLineRx Reports Positive Data from Ongoing Phase 2a
12:00am
6-K
EX-99
gf2nrvxpox69f5lyq
3 Nov 14
Current report (foreign)
12:00am
6-K
EX-99
y4rhzedyhleobvda1
17 Sep 14
Current report (foreign)
12:00am
6-K
EX-99
u3x4mmy37rnlf s6
3 Sep 14
Current report (foreign)
12:00am
6-K
EX-99
35ubgd
16 Jun 14
BioLineRx Receives Approval to Commence
12:00am
424B2
859u aqj1tnr8t85l4
13 Jun 14
Prospectus for primary offering
12:00am
F-3
i5rtsf9 m55w
30 May 14
Shelf registration (foreign)
12:00am
6-K
EX-99
bmcnd 74jbm7
20 May 14
BioLineRx Reports First Quarter 2014 Financial Results
12:00am
6-K
EX-99
6xyem8 c3z5pc1
10 Apr 14
Current report (foreign)
12:00am
6-K
EX-99
e6quwfvzgmm9zbb7b
14 Mar 14
BioLineRx Announces Issuance of United States Patent
12:00am
6-K
EX-1.1
aqfel3w5 i4
7 Mar 14
BioLineRx Closes $24.1 Million Underwritten Public Offering
12:00am
424B5
4b033wu7
4 Mar 14
Prospectus supplement for primary offering
12:00am
6-K
EX-99.1
bqazuunv2x
3 Mar 14
Current report (foreign)
12:00am